206 related articles for article (PubMed ID: 12269963)
1. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Caletti G; Zinzani PL; Fusaroli P; Buscarini E; Parente F; Federici T; Peyre S; De Angelis C; Bonanno G; Togliani T; Pileri S; Tura S;
Aliment Pharmacol Ther; 2002 Oct; 16(10):1715-22. PubMed ID: 12269963
[TBL] [Abstract][Full Text] [Related]
2. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.
Yeh HZ; Chen GH; Chang WD; Poon SK; Yang SS; Lien HC; Chang CS; Chou G
J Gastroenterol Hepatol; 2003 Feb; 18(2):162-7. PubMed ID: 12542600
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors.
Pavlick AC; Gerdes H; Portlock CS
J Clin Oncol; 1997 May; 15(5):1761-6. PubMed ID: 9164183
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
6. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.
El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM
Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085
[TBL] [Abstract][Full Text] [Related]
7. [Endoscopic ultrasound (EUS) in initial assessment and follow-up of patients with MALT lymphoma treated drug therapy].
Pavlović AR; Krstić M; Tomić D; Bjelović M; Jesić R; Suvajdzić N
Acta Chir Iugosl; 2005; 52(1):83-9. PubMed ID: 16119319
[TBL] [Abstract][Full Text] [Related]
8. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F
Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118
[TBL] [Abstract][Full Text] [Related]
9. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
10. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
12. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome.
Diz-Lois Palomares MT; Souto Ruzo J; Yáñez López JA; Alvarez García A; Arnal Monreal F; Vázquez-Iglesias JL
Rev Esp Enferm Dig; 2002 Nov; 94(11):669-78. PubMed ID: 12690990
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
[TBL] [Abstract][Full Text] [Related]
15. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
[TBL] [Abstract][Full Text] [Related]
16. The impact of EUS in primary gastric lymphoma.
Janssen J
Best Pract Res Clin Gastroenterol; 2009; 23(5):671-8. PubMed ID: 19744632
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
18. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Steinbach G; Ford R; Glober G; Sample D; Hagemeister FB; Lynch PM; McLaughlin PW; Rodriguez MA; Romaguera JE; Sarris AH; Younes A; Luthra R; Manning JT; Johnson CM; Lahoti S; Shen Y; Lee JE; Winn RJ; Genta RM; Graham DY; Cabanillas FF
Ann Intern Med; 1999 Jul; 131(2):88-95. PubMed ID: 10419446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]